Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
4.940
+0.760 (18.18%)
At close: Jun 12, 2026, 4:00 PM EDT
4.950
+0.010 (0.20%)
After-hours: Jun 12, 2026, 7:53 PM EDT
Shattuck Labs Revenue
In the year 2025, Shattuck Labs had annual revenue of $1.00M, down -82.52%.
Revenue (ttm)
$1.00M
Revenue Growth
-82.52%
P/S Ratio
378.80
Revenue / Employee
$25,000
Employees
40
Market Cap
378.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.00M | -4.72M | -82.52% |
| Dec 31, 2024 | 5.72M | 4.06M | 245.26% |
| Dec 31, 2023 | 1.66M | 1.01M | 154.14% |
| Dec 31, 2022 | 652.00K | -29.37M | -97.83% |
| Dec 31, 2021 | 30.02M | 20.08M | 202.16% |
| Dec 31, 2020 | 9.93M | 47.00K | 0.48% |
| Dec 31, 2019 | 9.89M | -12.56M | -55.94% |
| Dec 31, 2018 | 22.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Puma Biotechnology | 227.18M |
| Verastem | 49.59M |
| Editas Medicine | 38.69M |
| X4 Pharmaceuticals | 9.01M |
| Compass Therapeutics | 850.00K |
STTK News
- 4 days ago - Shattuck Labs 10.9M share Spot Secondary priced at $4.00 - TheFly
- 4 days ago - Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering - GlobeNewsWire
- 5 days ago - Shattuck Labs TBA Spot Secondary; price range $4.00-$4.25 - TheFly
- 5 days ago - Shattuck Labs announces common stock offering, no amount given - TheFly
- 5 days ago - Shattuck Labs, Inc. Announces Proposed Public Offering - GlobeNewsWire
- 5 days ago - Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update - GlobeNewsWire
- 5 days ago - Shattuck Labs price target raised to $18 from $7 at Citi - TheFly
- 6 days ago - Shattuck Labs price target raised to $17 from $14 at Needham - TheFly